Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Trivalent influenza vaccine

Aliases
0.25ml Trivalent influenza vaccine(B/V), 0.25ml Trivalent influenza vaccine(B/Y), Trivalent influenza vaccine(BY)

3 clinical trials

2 indications

Indication
Influenza
Indication
Seasonal Influenza
Clinical trial
Immunogenicity and Safety of Quadrivalent Influenza Vaccine In 6 to 35 Months Population: a Randomized, Double-blind, Parallel-group Ⅱ Phase of Clinical Trials
Status: Completed, Estimated PCD: 2021-09-14
Clinical trial
An Randomized, Double-blind, Controlled Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35months
Status: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
An Open Phase I and Randomized, Double-blind, Controlled Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35months.
Status: Recruiting, Estimated PCD: 2023-12-20